Sitapride-M 50mg/500mg Tablet
By Sitapride-M
Rx
15 Tablet in a Strip

Composition
Sitagliptin(50mg) + Metformin(500mg)

Manufacturer - Micro Labs Ltd
27, RACE COURSE ROAD, BANGALORE-560 001, INDIA

Expires on or after
July, 2026

liver
"Sitapride-M 50mg/500mg Tablet may not be safe for individuals with liver disease and should be avoided. It is important to seek advice from your doctor before using this medication."

kidney
Sitapride-M 50mg/500mg Tablet requires caution in patients with kidney disease. Dose adjustment may be necessary, but it's not advised for severe kidney disease. Regular kidney function tests are recommended during treatment. Consult your doctor for proper guidance.

alcohol
Avoid consuming alcohol while taking Sitapride-M 50mg/500mg Tablet. Drinking alcohol may increase the risk of side effects.

driving
If you experience low or high blood sugar, avoid driving while taking Sitapride-M 50mg/500mg Tablet to prevent impaired focus and reaction time.

pregnancy
Sitapride-M 50mg/500mg Tablet may be unsafe during pregnancy. Animal studies show potential harm to the developing baby. Your doctor will assess the risks and benefits before prescribing. Please consult your doctor.

breastfeeding
Sitapride-M 50mg/500mg Tablet is likely unsafe during breastfeeding as it may pass into breastmilk and harm the baby. It is better to consult your doctor before using Sitapride-M 50mg/500mg Tablet.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹149
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024